Literature DB >> 31012155

Janus Gold Nanostars-Mesoporous Silica Nanoparticles for NIR-Light-Triggered Drug Delivery.

Andy Hernández Montoto1, Antoni Llopis-Lorente1,2, Mónica Gorbe1,3, José M Terrés1, Roberto Cao-Milán4, Borja Díaz de Greñu1,2, María Alfonso1,2, Javier Ibañez1, María D Marcos1,5,2,3, Mar Orzáez3, Reynaldo Villalonga6, Ramón Martínez-Máñez1,5,2,3, Félix Sancenón1,5,2,3.   

Abstract

Janus gold nanostar-mesoporous silica nanoparticle (AuNSt-MSNP) nanodevices able to release an entrapped payload upon irradiation with near infrared (NIR) light were prepared and characterized. The AuNSt surface was functionalized with a thiolated photolabile molecule (5), whereas the mesoporous silica face was loaded with a model drug (doxorubicin) and capped with proton-responsive benzimidazole-β-cyclodextrin supramolecular gatekeepers (N 1). Upon irradiation with NIR-light, the photolabile compound 5 photodissociated, resulting in the formation of succinic acid, which induced the opening of the gatekeeper and cargo delivery. In the overall mechanism, the gold surface acts as a photochemical transducer capable of transforming the NIR-light input into a chemical messenger (succinic acid) that opens the supramolecular nanovalve. The prepared hybrid nanoparticles were non-cytotoxic to HeLa cells, until they were irradiated with a NIR laser, which led to intracellular doxorubicin release and hyperthermia. This induced a remarkable reduction in HeLa cells viability.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  NIR light; drug delivery; gold; light-responsive nanodevices; mesoporous silica

Mesh:

Substances:

Year:  2019        PMID: 31012155     DOI: 10.1002/chem.201900750

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

1.  Hybrid Hydrogels for Synergistic Periodontal Antibacterial Treatment with Sustained Drug Release and NIR-Responsive Photothermal Effect.

Authors:  Jian Lin; Zhiqi He; Fen Liu; Jie Feng; Chengyi Huang; Xueli Sun; Hui Deng
Journal:  Int J Nanomedicine       Date:  2020-07-29

2.  Horseradish Peroxidase-Functionalized Gold Nanoconjugates for Breast Cancer Treatment Based on Enzyme Prodrug Therapy.

Authors:  Gema Vivo-Llorca; Ángela Morellá-Aucejo; Alba García-Fernández; Paula Díez; Antoni Llopis-Lorente; Mar Orzáez; Ramón Martínez-Máñez
Journal:  Int J Nanomedicine       Date:  2022-01-26

Review 3.  Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment.

Authors:  Eleen Dayana Mohamed Isa; Haslina Ahmad; Mohd Basyaruddin Abdul Rahman; Martin R Gill
Journal:  Pharmaceutics       Date:  2021-01-24       Impact factor: 6.321

4.  Janus Magnetic Nanoplatform for Magnetically Targeted and Protein/Hyperthermia Combination Therapies of Breast Cancer.

Authors:  Shuting Zuo; Jing Wang; Xianquan An; Yan Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-03-08

5.  Janus-Nanojet as an efficient asymmetric photothermal source.

Authors:  Javier González-Colsa; Alfredo Franco; Fernando Bresme; Fernando Moreno; Pablo Albella
Journal:  Sci Rep       Date:  2022-08-20       Impact factor: 4.996

Review 6.  Recent Advance in Tumor Microenvironment-Based Stimuli-Responsive Nanoscale Drug Delivery and Imaging Platform.

Authors:  Fengzhi Cui; Jianhua Liu; Siwen Pang; Bo Li
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

Review 7.  Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability.

Authors:  Daniel Andrés Real; Karen Bolaños; Josefina Priotti; Nicolás Yutronic; Marcelo J Kogan; Rodrigo Sierpe; Orlando Donoso-González
Journal:  Pharmaceutics       Date:  2021-12-10       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.